Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.65

-0.56 (-3.25%)

At close: Oct 30, 2026, 4:00 PM EDT

16.71

+0.06 (0.36%)

After-hours: Oct 30, 2026, 5:03 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	321.74	283.06	235.13	175.51	134.03	45.61
Revenue Growth	21.04%	20.38%	33.97%	30.95%	193.89%	-9.01%
Cost of Revenue	49.6	65.17	49.03	63.79	50.65	52.23
Gross Profit	272.14	217.89	186.1	111.72	83.38	-6.63
Selling, General & Admin	99.48	101.79	172.03	195.04	196.37	173.54
Other Operating Expenses	-22	-0.17	1.55	2.48	-1.52	0.57
Operating Expenses	106.08	101.62	173.58	197.52	194.85	174.11
Operating Income	166.07	116.26	12.52	-85.79	-111.47	-180.74
Interest Expense	-3.87	-4.33	-4.84	-2.78	-	-
Interest & Investment Income	14.63	13.57	16.97	17	5.12	0.53
Currency Exchange Gain (Loss)	-9.7	-9.7	5.9	-5.9	-	-
EBT Excluding Unusual Items	167.12	115.8	30.55	-77.47	-106.35	-180.21
Merger & Restructuring Charges	-	-1.65	-23.11	-	-	-
Pretax Income	167.12	114.16	7.45	-77.47	-106.35	-180.21
Income Tax Expense	-147.15	-173.05	1.7	0.55	1.83	0.76
Net Income	314.27	287.2	5.75	-78.02	-108.18	-180.97
Net Income to Common	314.27	287.2	5.75	-78.02	-108.18	-180.97
Net Income Growth	303.75%	4893.08%	-	-	-	-
Shares Outstanding (Basic)	132	134	143	143	142	129
Shares Outstanding (Diluted)	136	139	146	143	142	129
Shares Change	-3.83%	-5.13%	2.07%	0.93%	9.70%	9.20%
EPS (Basic)	2.38	2.14	0.04	-0.54	-0.76	-1.40
EPS (Diluted)	2.31	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	320.31%	5075.00%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	177.03	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Per Share	1.30	0.98	0.30	-0.24	-0.56	-1.22
Gross Margin	84.58%	76.98%	79.15%	63.66%	62.21%	-14.53%
Operating Margin	51.62%	41.07%	5.32%	-48.88%	-83.17%	-396.31%
Profit Margin	97.68%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
Free Cash Flow Margin	55.02%	47.84%	18.76%	-19.47%	-59.55%	-346.44%
EBITDA	185.42	135.71	31.96	-74.14	-108.76	-177.97
EBITDA Margin	57.63%	47.95%	13.59%	-42.24%	-81.15%	-
D&A For EBITDA	19.36	19.45	19.45	11.65	2.71	2.76
EBIT	166.07	116.26	12.52	-85.79	-111.47	-180.74
EBIT Margin	51.62%	41.07%	5.32%	-48.88%	-83.17%	-
Effective Tax Rate	-	-	22.77%	-	-	-
Revenue as Reported	321.74	283.06	235.13	175.51	134.03	45.61

SEC Filings: 10-K · 10-Q